![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MabCure Inc (CE) | USOTC:MBCI | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date
of earliest event reported): September 17, 2010
MABCURE
INC.
(Exact name of registrant as specified in its
charter)
Nevada
(State or other jurisdiction of
incorporation)
333-141131
(Commission File Number)
20-4907813
(IRS Employer Identification No.)
De Schiervellaan 3/B1
3500 Hasselt, Belgium
(Address of principal executive offices and Zip Code)
+32 (48) 7425303
(Registrant's telephone number,
including area code)
(Former name or former address, if
changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
TABLE OF CONTENTS
Item 1.01 | Entry into a Material Definitive Agreement |
Item 9.01 | Financial Statements and Exhibits |
Signatures
Exhibit Index | |
Ex-10.1 | Amendment to the Subscription Agreement by and between Registrant and Paramount Trading Company, signed on September 17, 2010. |
- 2 -
Section 1 - Registrants Business and Operations
Item 1.01. Entry into a Material Definitive Agreement .
Amendment of Subscription Agreement
On September 17, 2010, the Registrant entered into an amendment of its Subscription Agreement with Paramount Trading Company (Paramount) dated June 27, 2008, pursuant to which the Registrant and Paramount extended the term of the two-year warrants to purchase 1,300,000 shares of common stock of Registrant until June 27, 2012, and reset the exercise price of such two-year warrants to $0.50 per share.
A copy of the amendment is attached hereto as Exhibit 10.1 and is incorporated herein by reference. The foregoing description of the amendment is qualified in its entirety by reference to the full text of the amendment.
The Original Subscription Agreement
The original Subscription Agreement provided for the sale of 1,300,000 units of our securities at a price of $1.00 per unit for aggregate proceeds of $1,300,000. Each unit consisted of: (i) one common share; (ii) one share purchase warrant entitling the holder to purchase one common share for a period of twelve months commencing on June 27, 2008, at an exercise price of $1.25 per common share (One-Year Warrants); and (iii) one share purchase warrant entitling the holder to purchase one common share for a period of twenty-four months commencing on June 27, 2008, at an exercise price of $1.25 per common share (Two-Year Warrants). The Subscription Agreement was described in more detail in the Registrants Current Report on Form 8-K filed with the SEC on July 10, 2008.
- 3 -
Section 9 Financial Statements and Exhibits
Item 9.01. | Financial Statements and Exhibits. |
Exhibit No. | Description | |
Exhibit 10.1 | Amendment to the Subscription Agreement by and between Registrant and Paramount Trading Company, signed on September 17, 2010. |
- 4 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MABCURE INC. | ||
(Registrant) | ||
By: | /s/ Dr. Amnon Gonenne | |
Dr. Amnon Gonenne | ||
President and Chief Executive Officer | ||
Date: September 20, 2010 |
1 Year MabCure (CE) Chart |
1 Month MabCure (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions